Article Text
Abstract
Gastrosplenic fistula is a rare and potentially fatal clinical entity unknown to most healthcare providers. Its diagnosis and management are challenging; and addressing it too late can have devastating consequences for patients. To increase awareness about this pathology, we hereby present a case of asymptomatic gastrosplenic fistula arising from a diffuse large B cell lymphoma in a 60-year-old Caucasian man with no significant medical history. The patient was successfully treated with open en-bloc splenectomy and partial gastrectomy. The patient was discharged from the hospital 3 days after the surgery. At 1-month postoperatively, the patient was asymptomatic and presented no complication of the surgery. He went on to finish six cycles of chemotherapy (R-EPOCH, rituximab, etoposide phosphate, prednisone, vincristine sulfate, cyclophosphamide, doxorubicin hydrochloride) and achieved complete metabolic response. At 2 years after the surgery, the patient remains asymptomatic and presents no sign of disease recurrence.
- malignant and benign haematology
- chemotherapy
- stomach wall
- surgery
- gastroenterology
Statistics from Altmetric.com
Footnotes
Contributors SM: conceptualisation, acquisition of data, writing—original draft, writing—review and editing. CA: conceptualisation, writing—original draft, writing—review and editing. F-CM: conceptualisation, writing—original draft, writing—review and editing. All authors have read and agreed to the published version of the manuscript.
Funding This study was funded by Université de Sherbrooke (Département de chirurgie).
Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.